May 18, 2015 / 5:24 AM / 3 years ago

BRIEF-Pharming Group enters into collaboration with Clinigen Group

May 18 (Reuters) - Pharming Group NV :

* Enters into an international global access collaboration with Clinigen Group for HAEi

* HAEi GAP program will provide access to RUCONEST (Conestat Alfa) to eligible patients with hereditary angioedema (HAE)

Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below